All News

Following an announcement that hospitals are to bypass the CDC and send all coronavirus disease 2019 (COVID-19)–related information to a central database, questions have been raised as to the future of COVID-19 data transparency and politicization.

Recognizing trends in health care that align with the COVID-19 pandemic and related racial disparities can improve the design of timely and effective strategies by employers to safely return employees to the workplace. Some of these efforts include less wait time for testing results, an improved focus on social determinants of health, and greater accessibility to care, said Lauren Vela, MBA, senior director at Pacific Business Group on Health.

A combination of machine learning and random optimization may aid in predicting medication overuse in migraineurs, if clinical/biochemical features, drug exposure, and lifestyle are taken into consideration, according to a study published in Computational and Structural Biotechnology Journal.

Subclinical changes in retinochoroidal vasculature occur in obese individuals, according to a study published in PLoS ONE. Surgical intervention, such as bariatric surgery, may have a favorable outcome on the choroidal thickness in these patients’ eyes.

California Governor Gavin Newsom announced yesterday the closure of indoor facilities statewide, amid a resurgence of coronavirus disease 2019 cases; US District Judge Theodore Chuang waived the in-person visit requirement to a hospital, clinic, or medical office to receive an abortion pill, due to the pandemic; a diet high in fruits and vegetables may halve the risk of developing type 2 diabetes.

A pair of late-breaking abstracts presented during AIDS 2020, this year’s virtual meeting of the International AIDS Society, detailed the effects that the coronavirus disease 2019 pandemic has had on trends in at-risk sexual behaviors and pre-exposure prophylaxis (PrEP) use, both in the United States and in Australia, due to shelter-in-place orders and social distancing.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo